9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one

9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one is a complex pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients (APIs) and advanced bioactive compounds. Its fused heterocyclic isoquinolinone framework, combined with hydroxyl functional groups, makes it a valuable structural building block in medicinal chemistry.

This intermediate is manufactured with high purity and controlled impurity profiles to ensure consistency, stability, and reliable performance in downstream synthetic processes. It is suitable for research and development, process optimization, and scale-up for commercial pharmaceutical manufacturing, supporting the development of therapeutics across diverse applications.